Results 121 to 130 of about 3,251,666 (288)

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

YESS: A feasibility study of a supported employment program for youths with mental health disorders. [PDF]

open access: yesFront Psychiatry, 2022
Ow N   +5 more
europepmc   +1 more source

Fiscal systems and female employment in Europe [PDF]

open access: yes, 2009
Before the economic crisis set in, there was evidence of some convergence on the Lisbon target employment rate for women (Eurostat Statistics in Focus 99/2008).
Camilleri-Cassar, Frances   +3 more
core  

Survey of Employment Tribunal Applications, 2018

open access: yes, 2021
copyright UK Data Service and data collection copyright owner.The Survey of Employment Tribunal Applications (SETA) series aims to provide information on the characteristics of the parties in, and the key features of, employment ...
Department for Business, Innovation and Skills, Employment Market Analysis and Research
core  

Preoperative circulating tumor cells integrated with imaging analysis for prognostic evaluation in head and neck squamous cell carcinoma

open access: yesMolecular Oncology, EarlyView.
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach   +9 more
wiley   +1 more source

Call to action

open access: yes, 2010
Joyce Dean, Dean/Ross Associates, and Cesilee Coulson, the Washington Initiative for Supported Employment.Title from PDF cover (viewed on April 22, 2020)."The Employment First Outreach Project."This archived document is maintained by the State Library of

core  

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

open access: yesMolecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy